These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1889 related items for PubMed ID: 31064233

  • 1. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M, Sahin Ersoy G, Yayla Abide C, Sanverdi İ, Devranoglu B, Kutlu T, Çevik Ö.
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [Abstract] [Full Text] [Related]

  • 2. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study.
    Temur M, Calan M, Akşit M, Yılmaz Ö, Çift T, Akselim B, Dinçgez Çakmak B, Üstünyurt E.
    Ginekol Pol; 2017 Oct; 88(10):517-522. PubMed ID: 29192411
    [Abstract] [Full Text] [Related]

  • 3. Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome.
    Cao S, Hu Y.
    Biosci Rep; 2021 Sep 30; 41(9):. PubMed ID: 34427289
    [Abstract] [Full Text] [Related]

  • 4. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.
    Sahin Ersoy G, Altun Ensari T, Vatansever D, Emirdar V, Cevik O.
    Gynecol Endocrinol; 2017 Feb 30; 33(2):119-123. PubMed ID: 27690684
    [Abstract] [Full Text] [Related]

  • 5. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P.
    Clin Endocrinol (Oxf); 2015 Jul 30; 83(1):98-104. PubMed ID: 25440474
    [Abstract] [Full Text] [Related]

  • 6. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.
    Am J Physiol Endocrinol Metab; 2009 Feb 30; 296(2):E238-43. PubMed ID: 18957615
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.
    Cengiz H, Ekin M, Dagdeviren H, Yildiz Ş, Kaya C, Kanawati A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep 30; 180():46-50. PubMed ID: 25036408
    [Abstract] [Full Text] [Related]

  • 8. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 30; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 9. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.
    Shen SH, Shen SY, Liou TH, Hsu MI, Chang YC, Cheng CY, Hsu CS, Tzeng CR.
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep 30; 192():66-71. PubMed ID: 26177495
    [Abstract] [Full Text] [Related]

  • 10. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.
    Caglar GS, Kahyaoglu I, Pabuccu R, Demirtas S, Seker R.
    Arch Gynecol Obstet; 2013 Oct 30; 288(4):905-10. PubMed ID: 23553200
    [Abstract] [Full Text] [Related]

  • 11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 12. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U, Duran C, Ecirli S.
    J Endocrinol Invest; 2017 May 07; 40(5):487-497. PubMed ID: 27838846
    [Abstract] [Full Text] [Related]

  • 13. Circulating neuregulin-1 levels in polycystic ovary syndrome.
    Arpacı H.
    J Obstet Gynaecol; 2019 May 07; 39(4):504-509. PubMed ID: 30634887
    [Abstract] [Full Text] [Related]

  • 14. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun 07; 189():19-23. PubMed ID: 25837320
    [Abstract] [Full Text] [Related]

  • 15. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome.
    Fonseca HP, Brondi RS, Piovesan FX, Miklos TG, Aldrighi JM.
    Gynecol Endocrinol; 2014 Sep 07; 30(9):667-70. PubMed ID: 24898132
    [Abstract] [Full Text] [Related]

  • 16. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M, Duran C, Guney I, Elmas H, Ayhan M, Erdem SS.
    Clin Investig Arterioscler; 2020 Sep 07; 32(6):256-262. PubMed ID: 32773256
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L, Lv S, Li F, Yu X, Bai E, Yang X.
    Front Endocrinol (Lausanne); 2020 Sep 07; 11():171. PubMed ID: 32296394
    [Abstract] [Full Text] [Related]

  • 18. Serum AMH levels and insulin resistance in women with PCOS.
    Sahmay S, Aydogan Mathyk B, Sofiyeva N, Atakul N, Azemi A, Erel T.
    Eur J Obstet Gynecol Reprod Biol; 2018 May 07; 224():159-164. PubMed ID: 29605710
    [Abstract] [Full Text] [Related]

  • 19. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.
    Woo HY, Kim KH, Rhee EJ, Park H, Lee MK.
    Endocr J; 2012 May 07; 59(9):781-90. PubMed ID: 22673409
    [Abstract] [Full Text] [Related]

  • 20. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J, Bergh T, Berne C, Lithell H.
    Clin Endocrinol (Oxf); 1994 Oct 07; 41(4):463-71. PubMed ID: 7955457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 95.